Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up – Time to Buy?

Shares of Merck KGaA (OTCMKTS:MKGAF) gapped up before the market opened on Friday . The stock had previously closed at $151.95, but opened at $159.1320. Merck KGaA shares last traded at $159.0510, with a volume of 25 shares traded.

Merck KGaA Stock Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock’s 50-day moving average price is $162.66 and its 200-day moving average price is $149.52. The company has a market cap of $20.54 billion, a P/E ratio of 24.26 and a beta of 0.96.

Institutional Trading of Merck KGaA

A number of institutional investors have recently bought and sold shares of the business. MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Merck KGaA during the second quarter worth approximately $4,896,000. Puzo Michael J bought a new stake in shares of Merck KGaA in the second quarter valued at approximately $2,230,000. Somerville Kurt F acquired a new stake in Merck KGaA during the second quarter worth approximately $1,997,000. Pinnacle Holdings LLC acquired a new stake in Merck KGaA during the second quarter worth approximately $1,487,000. Finally, North Star Asset Management Inc. bought a new position in Merck KGaA during the 2nd quarter worth $1,411,000. Institutional investors own 0.10% of the company’s stock.

About Merck KGaA

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest operating pharmaceutical and chemical companies. The business serves customers in more than 60 countries through three operating sectors: Healthcare, Life Science and Electronics.

The Healthcare sector develops and markets prescription medicines and specialty therapies, with activities focused on areas including oncology, neurology and immunology, fertility, and endocrinology.